- Home
- FVR vs GNFT Comparison
FVR vs GNFT Comparison
Compare FVR & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVR
- GNFT
- Stock Information
- Founded
- FVR 2016
- GNFT 1999
- Country
- FVR United States
- GNFT France
- Employees
- FVR N/A
- GNFT 180
- Industry
- FVR
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FVR
- GNFT Health Care
- Exchange
- FVR NYSE
- GNFT Nasdaq
- Market Cap
- FVR 227.7M
- GNFT 186.3M
- IPO Year
- FVR 2024
- GNFT 2019
- Fundamental
- Price
- FVR $11.73
- GNFT $3.66
- Analyst Decision
- FVR Hold
- GNFT Strong Buy
- Analyst Count
- FVR 5
- GNFT 1
- Target Price
- FVR $16.80
- GNFT $13.00
- AVG Volume (30 Days)
- FVR 346.3K
- GNFT 4.2K
- Earning Date
- FVR 08-15-2025
- GNFT 04-24-2025
- Dividend Yield
- FVR 7.36%
- GNFT N/A
- EPS Growth
- FVR N/A
- GNFT N/A
- EPS
- FVR N/A
- GNFT 0.03
- Revenue
- FVR $60,901,000.00
- GNFT $73,187,701.00
- Revenue This Year
- FVR $18.42
- GNFT $15.98
- Revenue Next Year
- FVR $6.26
- GNFT N/A
- P/E Ratio
- FVR N/A
- GNFT $120.95
- Revenue Growth
- FVR 15.85
- GNFT 105.01
- 52 Week Low
- FVR $10.61
- GNFT $2.55
- 52 Week High
- FVR $19.76
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- FVR N/A
- GNFT 40.81
- Support Level
- FVR N/A
- GNFT $3.61
- Resistance Level
- FVR N/A
- GNFT $3.95
- Average True Range (ATR)
- FVR 0.00
- GNFT 0.14
- MACD
- FVR 0.00
- GNFT -0.02
- Stochastic Oscillator
- FVR 0.00
- GNFT 18.06
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.